EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

SARS-CoV-2 Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis

Sofia De Stefanis, Francesca Colavita iD, Fabrizio Maggi iD, Manuela Antonioli iD

Viruses · 2026

DOI: 10.3390/v18020247 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Sofia De Stefanis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ph.D. Program in Cellular and Molecular Biology, Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy. Hauptthemen laut MEDLINE: COVID-19, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, University of Rome Tor Vergata.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In December 2019, the world experienced the emergence of a new virus, SARS-CoV-2, which caused the 2020 pandemic. SARS-CoV-2 causes COVID-19, primarily affecting the respiratory system, as well as the gastrointestinal tract. Remarkably, one in eight COVID-19 patients develops Long COVID, which is linked to SARS-CoV-2 persistence in the gastrointestinal tract, resulting in chronic inflammation and microbiota dysregulation. Given that gut microbiota dysbiosis plays a pivotal role in antiviral defense and gastrointestinal conditions, here we examine emerging evidence on how persistent SARS-CoV-2 infection may contribute to the aetiology of enteric disorders. In particular, we emphasise the intricate connection between chronic inflammation caused by persistent SARS-CoV-2 infection (e.g., irritable bowel syndrome and inflammatory bowel disease) and the possible development of diseases such as Crohn’s disease and ulcerative colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Gastrointestinal MicrobiomeHumansSARS-CoV-2Post-Acute COVID-19 SyndromeDysbiosisPandemicsGastrointestinal TractInflammatory Bowel DiseasesInflammation

Stichwörter der Autor:innen

Long COVIDSARS-CoV-2gut microbiota

Autor:innen und Institutionen

  • Ph.D. Program in Cellular and Molecular Biology, Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • Laboratory of Virology and Laboratories of Biosafety, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, 00149 Rome, Italy.
  • Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, 00149 Rome, Italy.
  • Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.

ORCID-Profile: Francesca Colavita, Fabrizio Maggi, Manuela Antonioli

Förderung

  • Ministero della Salute
  • University of Rome Tor Vergata

Zitieren

APA

De Stefanis, S., Colavita, F., Maggi, F., & Antonioli, M. (2026). SARS-CoV-2 Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis. Viruses. https://doi.org/10.3390/v18020247

Vancouver

De Stefanis S, Colavita F, Maggi F, Antonioli M. SARS-CoV-2 Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis. Viruses. 2026. doi:10.3390/v18020247

BibTeX
@article{DeStefanis2026,
  author = {De Stefanis, Sofia and Colavita, Francesca and Maggi, Fabrizio and Antonioli, Manuela},
  title = {SARS-CoV-2 Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18020247}
}
Kostenlos starten →